What does this research mean for the field?

While international migraine guidelines share core diagnostic and foundational treatment principles, they diverge significantly in the positioning of and access to newer therapies like CGRP monoclonal antibodies and gepants due to regional availability and insurance constraints. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To compare international clinical guidelines for migraine diagnosis and management, identifying consensus, differences, and clinical evidence gaps.

August 22, 2026Current Opinion in Neurology

A global comparison of clinical guidelines for the diagnosis and management of migraine: similarities, differences, and gaps

View Full Paper

Ask AI

Bookmark

Authors

FCFred Cohen

Discussion

Member takes

Overview

Review demonstrates global consensus on standard acute migraine therapies alongside disparities in access to newer targeted preventives, highlighting the need for harmonized equitable care.

Key Points

To compare international clinical guidelines for migraine diagnosis and management, identifying consensus, differences, and clinical evidence gaps.
Reviewed guideline repositories and professional society websites published between 2012 and 2025.
Synthesized diagnostic and therapeutic recommendations from American, British, Italian, Japanese, French, and International Headache Society guidelines.
All guidelines utilize ICHD-3 criteria, recommend early acute treatment with analgesics/NSAIDs, universally endorse triptans for moderate-to-severe attacks, and support standard oral preventives (beta-blockers, antiseizure medications, TCAs).
Guideline divergence centers on novel therapies; American and Japanese guidelines position CGRP monoclonal antibodies and gepants as first-line preventives, whereas British and French guidelines impose restrictions based on cost and insurance.
Substantial evidence gaps persist across guidelines regarding the management of pediatric, geriatric, and pregnant populations, as well as the long-term safety of emerging therapies.

Cite This Study

Fred Cohen (2026) studied this question.

synapsesocial.com/papers/6a895f53ca7ade938187ddb5 https://doi.org/10.1097/wco.0000000000001510

View Full Paper

Ask AI

Bookmark

August 22, 2026Current Opinion in Neurology

A global comparison of clinical guidelines for the diagnosis and management of migraine: similarities, differences, and gaps

View Full Paper

Ask AI

Bookmark

Authors

FCFred Cohen

Discussion

Member takes

Overview

Review demonstrates global consensus on standard acute migraine therapies alongside disparities in access to newer targeted preventives, highlighting the need for harmonized equitable care.

Key Points

To compare international clinical guidelines for migraine diagnosis and management, identifying consensus, differences, and clinical evidence gaps.
Reviewed guideline repositories and professional society websites published between 2012 and 2025.
Synthesized diagnostic and therapeutic recommendations from American, British, Italian, Japanese, French, and International Headache Society guidelines.
All guidelines utilize ICHD-3 criteria, recommend early acute treatment with analgesics/NSAIDs, universally endorse triptans for moderate-to-severe attacks, and support standard oral preventives (beta-blockers, antiseizure medications, TCAs).
Guideline divergence centers on novel therapies; American and Japanese guidelines position CGRP monoclonal antibodies and gepants as first-line preventives, whereas British and French guidelines impose restrictions based on cost and insurance.
Substantial evidence gaps persist across guidelines regarding the management of pediatric, geriatric, and pregnant populations, as well as the long-term safety of emerging therapies.

Cite This Study

Fred Cohen (2026) studied this question.

synapsesocial.com/papers/6a895f53ca7ade938187ddb5 https://doi.org/10.1097/wco.0000000000001510

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark